Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Archives of General Surgery(Electronic Edition) ›› 2011, Vol. 05 ›› Issue (04): 320-325. doi: 10.3877/cma.j.issn.1674-0793.2011.04.012

Special Issue:

• Original Article • Previous Articles     Next Articles

Strategies of treatments for tumor recurrence of liver cancer after liver transplantation

Chun-hui QIU1, Hui ZHAO1, Hu-an CHEN1, Ying-hua CHEN1, Wei MENG1, Chi XU1, Shu-hong YI1, Hua LI1, Gen-shu WANG1, Jian ZHANG1, Yang YANG1, Chang-jie CAI1, Min-qiang LU1, Gui-hua CHEN1,()   

  1. 1. Department of Transplant Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2011-02-14 Online:2011-08-01 Published:2011-08-01
  • Contact: Gui-hua CHEN
  • About author:
    Corresponding author: CHEN Gui-hua, Email:

Abstract:

Objective

To investigate pre-treatment condition, mean survival time, survival rate, tumor progression condition, complications and treatment cost of transcatheter arterial chemoembolization(TACE), radiofrequency ablation(RFA) and orthotopic liver retransplantation(re-OLT).

Methods

Retrospective analysis of 53 cases reported for intrahepatic recurrence after liver transplantation of our hospital, from Jan. 2004 to Jun. 2009. There were 3 patients received surgical resection, 22 for TACE, 18 for RFA and 10 for re-OLT. The pre-treatment condition, survival time, tumor progression condition, complications and treatment cost of the patients of surgical resection are investigated. Treatment effect of the patients received TACE, RFA and re-OLT were compared and analyzed.

Results

Three patients received surgical resection. After 4-12 months follow-up, they had not been found complications and tumor progression, and they were still alive. The difference of mean survival time, survival rates and the tumor progression condition among TACE, RFA and re-OLT are considered no significant; But RFA was lower in severe degree of complication, especially the biliary complications, and the cost of treatment: RFA<TACE<re-OLT.

Conclusions

The curative effect among TACE, RFA and re-OLT are similar to one other in curing the tumor recurrence of liver cancer after liver transplantation. RFA is much lower than TACE and re-OLT in severe degree of complication and the cost of treatment.

Key words: Liver cancer, Liver transplantation, Recurrence treatment

京ICP 备07035254号-20
Copyright © Chinese Archives of General Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-87331056 E-mail: pwwxcma2007@126.com
Powered by Beijing Magtech Co. Ltd